MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Impact of parkinson’s disease on work disability: a cross-sectional study

S. Secades, C. Martin (Madrid, Spain)

Meeting: 2025 International Congress

Keywords: Parkinson’s

Category: Parkinson's Disease: Epidemiology, Phenomenology, Clinical Assessment, Rating Scales

Objective: To evaluate the impact of Parkinson’s disease (PD) on work disability and identify clinical and demographic factors associated with occupational impairment. Additionally, this study assesses the feasibility of the Work Disability Inventory (WDI) as a standardized tool for evaluating work-related disability in PD.

Background: PD affects daily activities, including employment. While PD patients retire earlier than the general population, the contributions of motor and non-motor symptoms, as well as workplace adaptations, remain underexplored. A standardized tool to measure work disability in PD is lacking, and the WDI may offer a valuable framework for future implementation.

Method: We conducted a  cross-sectional study in 100 PD patients (age 18-70) from the Madrid Parkinson’s Association’s Young Patients Group.  Data were collected via structured questionnaires, including demographic (age, education, employment type), clinical, and work-related variables (WDI, workplace adaptations). Non-motor symptoms and quality of life were assessed using the Non-Motor Symptoms Scale (NMSS) and Parkinson’s Disease Questionnaire (PDQ-39). Statistical analyses included group comparisons, correlation analysis, and multivariate regression models.

Results: PD patients had significantly higher WDI scores compared to matched controls (mean 42.3 ± 12.1 vs. 18.7 ± 9.5, p<0.001). A significant correlation was found between WDI and NMSS scores (R = 0.56, p=0.002), indicating a strong relationship between non-motor symptom burden and work disability. In subgroup analysis, depression (β = 1.82, p=0.008) and fatigue (β = 1.45, p=0.021) were the strongest predictors of work impairment. Among motor symptoms, bradykinesia severity was associated with higher WDI scores (R = 0.48, p=0.006). Workplace adaptations, particularly flexible hours and task modifications, were associated with a 25% reduction in WDI scores (p=0.014). A multivariate regression model identified NMSS score, bradykinesia severity, and lack of workplace adaptations as independent predictors of work disability (adjusted R² = 0.61, p<0.001).

Conclusion: Non-motor symptoms, particularly depression and fatigue, play a critical role in work disability among PD patients. Workplace adaptations significantly mitigate work impairment. These findings highlight the need for early interventions and workplace modifications to support employment retention in PD patients.

To cite this abstract in AMA style:

S. Secades, C. Martin. Impact of parkinson’s disease on work disability: a cross-sectional study [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/impact-of-parkinsons-disease-on-work-disability-a-cross-sectional-study/. Accessed October 5, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/impact-of-parkinsons-disease-on-work-disability-a-cross-sectional-study/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley